Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Balance exercise program reduced falls in people with multiple sclerosis - a single group pretest posttest trial.
Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils.
Immunological Hallmarks of JC Virus Replication in Multiple Sclerosis Patients on Long-Term Natalizumab.
About Tysabri
Investigational Laquinimod Demonstrates Its Potential as a New Oral Treatment For RRMS
Correlation of nitric oxide levels in the cerebellum and spinal cord of experimental autoimmune encephalomyelitis rats with clinical symptoms.
Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography.
T-bet or not T-bet: Taking the last bow on the autoimmunity stage.
Iranian family caregivers' challenges and issues in caring of multiple sclerosis patients: A descriptive explorative qualitative study.
Effects of multidisciplinary rehabilitation on chronic fatigue in multiple sclerosis: a randomized controlled trial.
VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses.
The role of regulatory T cells in neurodegenerative diseases.
Natalizumab-induced autoimmune hepatitis in a patient with multiple sclerosis.
Magnetic resonance imaging induced acute midfacial pain - incidental finding of a dislocated dental bur.
Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).
FTY720 is neuroprotective after cuprizone-induced central nervous system demyelination.
Kinin-mediated inflammation in neurodegenerative disorders.
Quetiapine, an Atypical Antipsychotic, Is Protective against Autoimmune-Mediated Demyelination by Inhibiting Effector T Cell Proliferation.
Natural, innate improvements in multiple sclerosis disability.
Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
Multiple sclerosis and glutamate excitotoxicity.
Identification of shared genes and pathways: a comparative study of multiple sclerosis susceptibility, severity and response to interferon Beta treatment.
Laquinimod CHMP/EMA opinion
Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
Mechanisms in the Development of Multiple Sclerosis Lesions: Reconciling Autoimmune and Neurodegenerative Factors.

Pages